On February 2nd, MICROTECH MED-B(02235) spent 139,000 Hong Kong dollars to repurchase 19,000 shares.
Weitai Medical-B (02235) announced that on February 2, 2026, the company spent 139,900 Hong Kong dollars to repurchase 19,000 shares.
MICROTECH MED-B (02235) announced that on February 2, 2026, the company spent 139,900 Hong Kong dollars to repurchase 19,000 shares.
Related Articles
CICC(03908): "21 Zhongjin C2" will be redeemed and delisted on February 9th.
SOLIS HOLDINGS (02227) subsidiary granted options, intending to sell Singapore property for SGD 21 million
ZCLOUD TECH CON (09900): Liu Zhiyi appointed as executive director.
CICC(03908): "21 Zhongjin C2" will be redeemed and delisted on February 9th.
SOLIS HOLDINGS (02227) subsidiary granted options, intending to sell Singapore property for SGD 21 million
ZCLOUD TECH CON (09900): Liu Zhiyi appointed as executive director.
RECOMMEND
Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026
Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026
2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026
